A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Manager/Senior Manager, Market Research

Product MarketingConfirmed live in the last 24 hours
Full-timeNew York, NY, USA

About the Job

Requirements

  • A bachelor's degree is required.
  • At least five years of pharmaceutical or biotech market research, brand marketing, sales, or other commercial leadership experience is required.
  • At least four years of qualitative and/or quantitative market research experience is required.
  • Ability to travel up to 10% of the time is required.
  • Ability to work on site Monday, Tuesday, and Thursday is required; candidates seeking fully remote roles will not be considered.

Responsibilities

  • Turn unstructured business issues and requests into action plans and projects that produce high-quality, meaningful, and actionable deliverables.
  • Plan, design, and conduct strategic and highly complex market research programs, leading the process from research design and sampling strategy through data collection and data analysis planning.
  • Provide key learnings and recommendations aligned with business objectives.
  • Translate and synthesize data, research, and analyses into actionable insights that deepen customer understanding across the central nervous system pipeline.
  • Provide thought leadership and subject matter expertise in market research.
  • Prioritize research resources to address critical business issues and decisions.
  • Maintain strategic partnership and alignment with Marketing, Sales, Market Access, Medical Affairs, and Executive Leadership.
  • Consider alternative methodologies for capturing the voice of customers, including healthcare professionals, patients, and payers, and explore innovative methods beyond standard approaches.
  • Identify, evaluate, and manage relationships with insights vendors.
  • Ensure projects comply with company standard operating procedures and general market research guidelines, and meet quality, timeliness, and budget expectations.
  • Use artificial intelligence-enabled tools and platforms to accelerate insight generation, identify patterns in large or unstructured datasets, and enhance the speed and depth of primary market research and competitive intelligence.

Desired Qualifications

  • An advanced degree, including an MBA or master's degree in a related field, is preferred.
  • Knowledge of secondary data sources used in the pharmaceutical industry.
  • Ability to investigate and uncover the reasons behind observed healthcare professional behaviors.
  • Experience applying artificial intelligence or generative artificial intelligence tools to market research workflows.
  • Strategic and critical thinking abilities and business acumen.
  • Analytical skills, including understanding the advantages and limitations of different analytical and quantitative approaches.
  • Familiarity with launch and pre-launch planning, tracking, and measurement.
  • Familiarity with direct-to-healthcare-professional, consumer, and payer strategies and tactics.
  • Oral, written, and presentation skills, including the ability to explain complex concepts clearly to varied audiences.
  • Central nervous system experience.
  • Ability to work collaboratively in a team-based environment.
  • Ability to balance multiple projects and workstreams simultaneously.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs